![Nutriband Inc. logo](/logos/NTRB.webp)
Nutriband Inc.
NASDAQ:NTRB
Overview | Financials
Company Name | Nutriband Inc. |
Symbol | NTRB |
Currency | USD |
Price | 4.43 |
Market Cap | 49,156,166 |
Dividend Yield | 0% |
52-week-range | 1.53 - 9.595 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Gareth Sheridan |
Website | https://nutriband.com |
An error occurred while fetching data.
About Nutriband Inc.
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD